Journal editors question sale of diet pill Meridia

September 1, 2010 By STEPHANIE NANO , Associated Press Writer

(AP) -- Editors of a top medical journal are questioning whether the diet pill Meridia should stay on the market even if it's restricted to people without heart disease.

A new study shows the appetite suppressant raises the risk of and stroke in people with heart problems.

The strongly worded editorial in Thursday's comes two weeks before government advisers review the prescription drug.

The weight-loss pill has already been pulled in Europe and U.S. drug regulators have added stronger warnings to the label.

The maker of the diet pill, Abbott Laboratories, says it's still appropriate for obese people who don't have and who can't lose weight through diet and exercise.

Explore further: Pill claims weight loss with no diet

0 shares

Related Stories

Pill claims weight loss with no diet

October 8, 2007

Akavar 20/50, a pill produced in Salt Lake City, has become the most recent product to advertise weight loss with no diet or exercise.

Health Canada warns against Meridia

October 16, 2007

Health Canada issued a warning for doctors not to prescribe the weight loss drug Meridia to people who may be at risk of serious heart-related side effects.

FDA to review first of 3 new weight loss drugs

July 12, 2010

(AP) -- Dieters, doctors and investors get their first extensive look at the first of a trio of new weight loss drugs this week. The hope is that the new drugs can succeed where many others have failed: delivering significant ...

Experimental diet pill shows promise, little risk

July 14, 2010

(AP) -- An experimental diet pill helped about half the people who tried it lose some weight and keep it off a year later, without the heart problems that some earlier drugs caused, a study found.

FDA panel rejects experimental weight loss pill

July 15, 2010

(AP) -- A panel of federal health experts dealt a surprising setback Thursday to a highly anticipated anti-obesity pill from Vivus Inc., saying the drug's side effects outweigh its ability to help patients lose weight.

Recommended for you

Machine Translates Thoughts into Speech in Real Time

December 21, 2009

(PhysOrg.com) -- By implanting an electrode into the brain of a person with locked-in syndrome, scientists have demonstrated how to wirelessly transmit neural signals to a speech synthesizer. The "thought-to-speech" process ...

Quantum Theory May Explain Wishful Thinking

April 14, 2009

(PhysOrg.com) -- Humans don’t always make the most rational decisions. As studies have shown, even when logic and reasoning point in one direction, sometimes we chose the opposite route, motivated by personal bias or simply ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.